Yizhou A. Liu

Washington University in St Louis School of Medicine
United States

PAPER Saikusa K, Kinumi T, Kato M

Development of amyloid β (1-42) certified reference material NMIJ CRM 6210-a.

Anal Bioanal Chem. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Limone A, Di Napoli C, Napolitano F, Imbò B, Minopoli G, Bagnoli S, Izzo A, Paladino S, Nacmias B, De Matteis MA, Montuori N, Lavecchia A, Sarnataro D

Targeting RPSA to modulate endosomal trafficking and amyloidogenesis in genetic Alzheimer's disease.

Biochim Biophys Acta Mol Basis Dis. 2025 Mar 2;1871(5):167753. Epub 2025 Mar 2 PubMed.

PAPER Zhang Z, Huang G, Gupta S, Sargent E, Tang H, Ding F

Determinants for Substoichiometric Inhibition of IAPP and Aβ Amyloid Aggregations by Bri2 BRICHOS.

ACS Chem Neurosci. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Kshirsagar S, Islam MA, Reddy AP, Reddy PH

Cell culture research in aging and Alzheimer's disease: The strategic use/reuse of untreated controls and savings people's tax dollars.

J Alzheimers Dis Rep. 2025;9:25424823241310716. Epub 2025 Jan 15 PubMed.

PAPER Liu JY, Tan CY, Luo L, Yin X

Gut microbiota may affect Alzheimer's disease through synaptic function mediated by CAMs pathway: A study combining Mendelian randomization and bioinformatics.

J Alzheimers Dis Rep. 2025;9:25424823241310719. Epub 2025 Jan 13 PubMed.

PAPER Klein BY, Ben-David I, Gofrit ON, Greenblatt CL

Repurposing peripheral immunocytes of Bacillus Calmette Guerin-vaccinated melanoma patients to reveal preventive Alzheimer's disease mechanisms, possibly via the unfolded protein response.

J Alzheimers Dis Rep. 2025;9:25424823241309664. Epub 2025 Feb 10 PubMed.

PAPER Ranganathan R, Li S, Sapozhnikov G, Wang S, Song YQ

Lower expression of BIN1's neuronal isoform in vulnerable excitatory neurons increases risk in Alzheimer's disease.

J Alzheimers Dis Rep. 2025;9:25424823241296018. Epub 2025 Jan 13 PubMed.

PAPER Sato K, Niimi Y, Ihara R, Iwata A, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Iwatsubo T

Sentiment analysis of social media responses to the approval of lecanemab for the treatment of Alzheimer's disease in Japan.

J Alzheimers Dis Rep. 2025;9:25424823241307639. Epub 2025 Jan 15 PubMed.

PAPER Lee YJ, Gonzales E, Wu Y, Braun KL, Martin P, Willcox B, Andel R

The association between activities and cognitive health: Stratified analysis by APOE ε4 status.

J Alzheimers Dis Rep. 2024;8(1):1502-1515. Epub 2024 Nov 24 PubMed.

PAPER Matthews DG, Khorani M, Bobe G, Caruso M, Magana AA, Gray NE, Quinn JF, Stevens JF, Maier CS, Soumyanath A

Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice.

J Alzheimers Dis Rep. 2024;8(1):1611-1638. Epub 2024 Dec 4 PubMed.

PAPER Siriwardhana C, Carrazana E, Liow K, Chen JJ

Cardio and cerebrovascular diseases risk among Alzheimer's disease patients and racial/ethnic disparities, based on Hawaii Medicare data.

J Alzheimers Dis Rep. 2024;8(1):1529-1540. Epub 2024 Nov 24 PubMed.

PAPER Wise J

Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug.

BMJ. 2025 Mar 3;388:r439. PubMed.

PAPER Du X, Wang H, Liu S, Song Y, Chen X, Chen Z, Zhou R, Du J, Zhang W, Gao R, Li H, Zhang G, Mao X, Chang L, Wu Y

Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway.

Prog Neurobiol. 2025 Mar 1;:102744. Epub 2025 Mar 1 PubMed.

PAPER Wang Q, Xu L, Shan Y, Shen W, Li L, Bi XA, Liu Z

CPST-GAN: Conditional Probabilistic State Transition Generative Adversarial Network With the Biomedical Large Foundation Models.

IEEE Trans Neural Netw Learn Syst. 2025 Feb 27;PP Epub 2025 Feb 27 PubMed.